89 related articles for article (PubMed ID: 10432679)
1. Resistance profiles of (+)2'-deoxy-3'-oxa-4'-thiocytidine and (-)2'-deoxy-3'-oxa-4'-thio-5-fluorocytidine.
Richard N; Salomon H; Oliveira M; Rando R; Wainberg MA
Nucleosides Nucleotides; 1999; 18(4-5):773-8. PubMed ID: 10432679
[TBL] [Abstract][Full Text] [Related]
2. Selection and characterization of human immunodeficiency virus type 1 variants resistant to the (+) and (-) enantiomers of 2'-deoxy-3'-oxa-4'-thio-5-fluorocytidine.
Richard N; Salomon H; Rando R; Mansour T; Bowlin TL; Wainberg MA
Antimicrob Agents Chemother; 2000 May; 44(5):1127-31. PubMed ID: 10770740
[TBL] [Abstract][Full Text] [Related]
3. Selection of resistance-conferring mutations in HIV-1 by the nucleoside reverse transcriptase inhibitors (+/-)dOTC and (+/-)dOTFC.
Richard N; Salomon H; Oliveira M; Rando R; Mansour T; Gu Z; Wainberg MA
Antivir Chem Chemother; 2000 Nov; 11(6):359-65. PubMed ID: 11227993
[TBL] [Abstract][Full Text] [Related]
4. Selection and characterization of HIV-1 variants resistant to the (+) and (-) enantiomers of 2'-deoxy-3'-oxa-4'-thiocytidine (dOTC).
Richar N; Quan Y; Salomon H; Hsu M; Bedard J; Harrigan PR; Rando R; Mansour T; Bowlin TL; Wainberg MA
Antivir Ther; 1999; 4(3):171-7. PubMed ID: 12731757
[TBL] [Abstract][Full Text] [Related]
5. Drug resistance and drug combination features of the human immunodeficiency virus inhibitor, BCH-10652 [(+/-)-2'-deoxy-3'-oxa-4'-thiocytidine, dOTC].
Taylor DL; Ahmed PS; Tyms AS; Wood LJ; Kelly LA; Chambers P; Clarke J; Bedard J; Bowlin TL; Rando RF
Antivir Chem Chemother; 2000 Jul; 11(4):291-301. PubMed ID: 10950391
[TBL] [Abstract][Full Text] [Related]
6. Anti-human immunodeficiency virus type 1 activity, intracellular metabolism, and pharmacokinetic evaluation of 2'-deoxy-3'-oxa-4'-thiocytidine.
de Muys JM; Gourdeau H; Nguyen-Ba N; Taylor DL; Ahmed PS; Mansour T; Locas C; Richard N; Wainberg MA; Rando RF
Antimicrob Agents Chemother; 1999 Aug; 43(8):1835-44. PubMed ID: 10428900
[TBL] [Abstract][Full Text] [Related]
7. Antiviral activity of 2'-deoxy-3'-oxa-4'-thiocytidine (BCH-10652) against lamivudine-resistant human immunodeficiency virus type 1 in SCID-hu Thy/Liv mice.
Stoddart CA; Moreno ME; Linquist-Stepps VD; Bare C; Bogan MR; Gobbi A; Buckheit RW; Bedard J; Rando RF; McCune JM
Antimicrob Agents Chemother; 2000 Mar; 44(3):783-6. PubMed ID: 10681360
[TBL] [Abstract][Full Text] [Related]
8. Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase.
Tisdale M; Kemp SD; Parry NR; Larder BA
Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5653-6. PubMed ID: 7685907
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the phenotypic susceptibility profiles of emtricitabine and lamivudine.
Borroto-Esoda K; Parkin N; Miller MD
Antivir Chem Chemother; 2007; 18(5):297-300. PubMed ID: 18046962
[TBL] [Abstract][Full Text] [Related]
10. The role of steric hindrance in 3TC resistance of human immunodeficiency virus type-1 reverse transcriptase.
Gao HQ; Boyer PL; Sarafianos SG; Arnold E; Hughes SH
J Mol Biol; 2000 Jul; 300(2):403-18. PubMed ID: 10873473
[TBL] [Abstract][Full Text] [Related]
11. Endogenous reverse transcriptase assays reveal synergy between combinations of the M184V and other drug resistance-conferring mutations in interactions with nucleoside analog triphosphates.
Quan Y; Gu Z; Li X; Liang C; Parniak MA; Wainberg MA
J Mol Biol; 1998 Mar; 277(2):237-47. PubMed ID: 9514745
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and potent anti-HIV activity of L-2',3'-didehydro-2',3'-dideoxy-2'-fluoro-4'-thiocytidine.
Choi Y; Choo H; Chong Y; Lee S; Olgen S; Schinazi RF; Chu CK
Org Lett; 2002 Jan; 4(2):305-7. PubMed ID: 11796076
[TBL] [Abstract][Full Text] [Related]
13. The influence of 3TC resistance mutation M184I on the fidelity and error specificity of human immunodeficiency virus type 1 reverse transcriptase.
Rezende LF; Drosopoulos WC; Prasad VR
Nucleic Acids Res; 1998 Jun; 26(12):3066-72. PubMed ID: 9611256
[TBL] [Abstract][Full Text] [Related]
14. Virologic and enzymatic studies revealing the mechanism of K65R- and Q151M-associated HIV-1 drug resistance towards emtricitabine and lamivudine.
Feng JY; Myrick FT; Margot NA; Mulamba GB; Rimsky L; Borroto-Esoda K; Selmi B; Canard B
Nucleosides Nucleotides Nucleic Acids; 2006; 25(1):89-107. PubMed ID: 16440988
[TBL] [Abstract][Full Text] [Related]
15. Anti-human immunodeficiency virus type 1 activity and resistance profile of 2',3'-didehydro-3'-deoxy-4'-ethynylthymidine in vitro.
Nitanda T; Wang X; Kumamoto H; Haraguchi K; Tanaka H; Cheng YC; Baba M
Antimicrob Agents Chemother; 2005 Aug; 49(8):3355-60. PubMed ID: 16048947
[TBL] [Abstract][Full Text] [Related]
16. Anti-human immunodeficiency virus and anti-hepatitis-B virus activities and toxicities of the enantiomers of 2'-deoxy-3'-oxa-4'-thiocytidine and their 5-fluoro analogues in vitro.
Mansour TS; Jin H; Wang W; Hooker EU; Ashman C; Cammack N; Salomon H; Belmonte AR; Wainberg MA
J Med Chem; 1995 Jan; 38(1):1-4. PubMed ID: 7837220
[No Abstract] [Full Text] [Related]
17. In vitro selection and analysis of human immunodeficiency virus type 1 resistant to derivatives of beta-2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine.
Hammond JL; Parikh UM; Koontz DL; Schlueter-Wirtz S; Chu CK; Bazmi HZ; Schinazi RF; Mellors JW
Antimicrob Agents Chemother; 2005 Sep; 49(9):3930-2. PubMed ID: 16127074
[TBL] [Abstract][Full Text] [Related]
18. Resistance profile of the new nucleoside reverse transcriptase inhibitor apricitabine.
Cahn P; Wainberg MA
J Antimicrob Chemother; 2010 Feb; 65(2):213-7. PubMed ID: 20007333
[TBL] [Abstract][Full Text] [Related]
19. Absolute bioavailability and disposition of (-) and (+) 2'-deoxy- 3'-oxa-4'-thiocytidine (dOTC) following single intravenous and oral doses of racemic dOTC in humans.
Smith PF; Forrest A; Ballow CH; Martin DE; Proulx L
Antimicrob Agents Chemother; 2000 Jun; 44(6):1609-15. PubMed ID: 10817717
[TBL] [Abstract][Full Text] [Related]
20. Pyrido [1,2a] indole derivatives identified as novel non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1.
Taylor DL; Ahmed PS; Chambers P; Tyms AS; Bedard J; Duchaine J; Falardeau G; Lavallée JF; Brown W; Rando RF; Bowlin T
Antivir Chem Chemother; 1999 Mar; 10(2):79-86. PubMed ID: 10335402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
